Find Investable Startups and Competitors
Search thousands of startups using natural language—just describe what you're looking for
Top 50 Self Healing Material
Discover the top 50 Self Healing Material startups. Browse funding data, key metrics, and company insights. Average funding: $5.4M.
Sort by
Tandem Repeat
Tandem Repeat develops Squitex, a protein-based fiber produced through carbon-negative methods, which offers unique stretch, strength, and self-healing properties for the textile industry. This technology addresses the high greenhouse gas emissions associated with traditional fabric production by providing a sustainable alternative that reduces environmental impact.
Funding: $5M+
Rough estimate of the amount of funding raised
TYBR Health
TYBR is developing a sprayable hydrogel designed to prevent internal organ scarring after surgical procedures, enhancing the body's natural healing process without synthetic materials. This technology aims to reduce the incidence of function-limiting adhesions, thereby minimizing recovery time and complications for patients.
Sole Biotechnology
Sole Biotechnology creates advanced hydrogel wound dressings and cosmetic face masks from sustainably produced bacterial cellulose. Their biocompatible and biodegradable biomaterials promote accelerated wound healing and skin rejuvenation, offering natural alternatives for medical and aesthetic applications.
Fibroheal Woundcare Pvt Ltd
Fibroheal specializes in utilizing silk proteins as a biomaterial for active wound care management, providing a range of products designed to enhance healing and reduce infection risk. The company addresses the need for effective wound treatment solutions in both clinical and home care settings, leveraging the unique properties of silk proteins to promote faster recovery.
Funding: $500K+
Rough estimate of the amount of funding raised
SanaHeal
Develops bioadhesive technologies inspired by natural adhesives, such as barnacle glue and spider silk, to create rapid, robust bonding solutions for wet, contaminated, and uneven biological surfaces. These technologies address challenges in medical applications, including wound healing and surgical adhesion, by providing coagulation-independent, strain-programmed, and multi-form factor solutions.
Funding: $3M+
Rough estimate of the amount of funding raised
Bioretec
Bioretec offers fully absorbable orthopedic fixation devices—RemeOs™, a magnesium‑based alloy screw, and Activa™, a self‑reinforced PLGA polymer screw—designed to provide fixation strength comparable to permanent metal implants while safely resorbing after bone healing. The implants feature bioactive surfaces, MRI‑conditional or radiolucent properties, and patented self‑locking and auto‑compression mechanisms that eliminate the need for secondary removal surgery and reduce imaging artifacts. This reduces patient morbidity, streamlines surgical workflows, and lowers the environmental impact of orthopedic procedures.
Funding: $10M+
Rough estimate of the amount of funding raised
Hy2Care
Hy2Care BV develops the CartRevive® hydrogel implant, which utilizes joint-tissue mimicking natural polymers to create a scaffold that supports the recovery of cartilage defects in joints. This technology addresses the need for effective healing of traumatic cartilage injuries, reducing pain and the risk of developing post-traumatic osteoarthritis.
Funding: $3M+
Rough estimate of the amount of funding raised
Linio Biotech
Linio Biotech develops Tience, a sterile cell-free tissue product that promotes the biological regeneration of damaged skin, addressing issues such as severe scars and skin defects. This technology enhances healing and improves skin texture, offering a safe alternative to traditional autologous methods like PRP and fat grafting.
Funding: $5M+
Rough estimate of the amount of funding raised
Tirecat Health
This healthcare company develops bioinspired polymer technology for medical applications. Their adaptable membrane offers antimicrobial, adhesive, and regenerative properties, improving patient outcomes in tissue regeneration and infection prevention.
Funding: $100K+
Rough estimate of the amount of funding raised
Pneuma
Pneuma develops OXYA™, a class of engineered living materials that incorporates microorganisms like algae, fungi, and bacteria to create sustainable products. Their proprietary SPIRO™ technology utilizes bioinspired processes to enhance material performance, addressing the environmental impact of traditional manufacturing methods.
BRINTER
Brinter develops 3D bioprinted biocomposite implants, known as BioMods™, specifically designed for soft tissue repair, starting with rotator cuff tears. These implants are fully resorbable and engineered to enhance tissue regeneration, addressing the limitations of traditional surgical implants in sports medicine.
Funding: $3M+
Rough estimate of the amount of funding raised
Regenosca
Regenosca's TissueSpan technology utilizes a unique mesh that facilitates the body's natural cell attraction and organization for effective soft tissue regeneration. This approach eliminates the need for harvesting the patient's own tissue, reducing surgical pain and complications associated with traditional urethral stricture repair methods.
Funding: $1M+
Rough estimate of the amount of funding raised
BRIJ Medical
BRIJ Medical develops the Brijjit® Scar Therapy device, which utilizes a proprietary medical-grade acrylic pressure-sensitive adhesive to secure surgical incisions without sutures or staples, promoting faster healing and reducing wound complications. This technology addresses the issues of wound breakdown and excessive scarring, achieving a 90% reduction in wound breakdown and a 38% decrease in scar area.
Funding: $10M+
Rough estimate of the amount of funding raised
Komment
Komment creates self-healing wikis that automatically document codebases by connecting to GitHub repositories. This platform helps developers quickly onboard, simplifies project handoffs, and automates knowledge capture for software teams.
Funding: $1M+
Rough estimate of the amount of funding raised
Surrozen
Surrozen is a biopharmaceutical company utilizing proprietary regenerative medicine technologies to enhance the body's natural healing processes. Their approach targets tissue repair and regeneration in response to injury and disease, aiming to improve patient outcomes in conditions with limited treatment options.
Funding: $10M+
Rough estimate of the amount of funding raised
Rovial Space
Rovial builds modular solar power platforms in GEO/MEO that are assembled and maintained in orbit by AI‑driven robotic units. Each launch can deploy 100 kW to multi‑megawatt arrays with self‑healing structures and a 15‑year design life, providing commercial and defense customers a reusable, high‑capacity power source for satellites, data centers, laser communications and lunar infrastructure. The platforms are accessed via a cloud‑based interface and standard electrical connectors for seamless payload integration.
CompPair
CompPair develops HealTech™ technology, which integrates self-healing capabilities into composite materials, allowing for rapid repairs and extending the lifespan of these structures. This approach addresses the issue of material waste in the composites industry by enabling the reuse and regeneration of damaged components, ultimately preserving their economic value.
Corryn Biotechnologies
Corryn Biotechnologies develops the HEALS device, a handheld applicator that utilizes patent-pending electrospinning technology to create a breathable, biodegradable mesh that mimics the natural extracellular matrix for complex wound care. This approach addresses the challenges of chronic wounds by enabling contactless dressing application, reducing pain during treatment, and allowing for tailored material selection at the point of care.
Funding: $500K+
Rough estimate of the amount of funding raised
GelSana
GelSana Therapeutics develops highly elastic wound dressings using proprietary polymer chemistry that conform to various wound types, reducing inflammation and preventing infection. These dressings also enable sustained drug delivery, addressing the challenges of chronic wound healing.
Funding: $3M+
Rough estimate of the amount of funding raised
Gel4Med
Gel4Med utilizes its proprietary Smart Materials Platform™ to develop biosynthetic matrices for wound care and surgical reconstruction. The company’s G4Derm™ and G4Derm™ Plus products specifically address the challenges of managing complex wounds, enhancing healing through a biomimetic approach.
Funding: $100K+
Rough estimate of the amount of funding raised
VivArt-X
VivArt-X develops regenerating materials specifically designed for women's health applications, utilizing biocompatible polymers that promote tissue regeneration. This technology addresses the need for effective and safe solutions in medical devices and treatments related to women's health issues.
Funding: $500K+
Rough estimate of the amount of funding raised
Piomic
The startup offers personalized wound care solutions utilizing advanced biomaterials and smart dressings that promote faster healing and reduce infection risk. Their technology addresses the challenges of chronic wounds by providing tailored treatment options that enhance patient outcomes and minimize healthcare costs.
Funding: $10M+
Rough estimate of the amount of funding raised
Fesarius Therapeutics
Fesarius Therapeutics is developing the DermiSphere™, a micropatterned hydrogel wound dressing that incorporates collagen microspheres to enhance cell invasion and vascularization for full-thickness skin loss treatment. This technology addresses the limitations of traditional wound care by promoting rapid tissue regeneration and improving patient outcomes in a single surgical step.
Funding: $5M+
Rough estimate of the amount of funding raised
SDIP Innovations
SDIP Innovations develops JAZBI™ bioresorbable bone implants that mimic natural bone remodeling to facilitate the healing of fractured bones. These implants fully resorb into bone tissue, eliminating the need for removal surgeries and significantly reducing costs compared to traditional metallic fixations.
Funding: $2M+
Rough estimate of the amount of funding raised
Quthero
Quthero develops a bioengineered wound management gel utilizing its proprietary Q-peptide technology, derived from Angiopoietin-1, to enhance cell migration and collagen deposition for faster healing. This gel effectively reduces inflammation and improves skin quality in post-aesthetic procedures, addressing the need for efficient wound care in dermatology.
Funding: $1M+
Rough estimate of the amount of funding raised
Chitogel Limited
Chitogel develops a specialized wound healing gel designed for endoscopic sinus surgery, utilizing advanced biocompatible materials to promote faster tissue regeneration. This technology addresses the challenge of prolonged healing times and complications associated with sinus surgery, enhancing patient recovery outcomes.
Funding: $5M+
Rough estimate of the amount of funding raised
Temple ORTHOBiologics
TX-33 is an intra-articular therapeutic solution that promotes normal tissue resolution instead of scar formation following joint or muscle injury or surgery. This biomaterial-based treatment aids athletes and active individuals in achieving optimal muscle repair and recovery.
Mimicrete
Mimicrete develops biomimetic self-healing concrete that utilizes a vascular network containing a healing agent to autonomously repair cracks as they form. This technology extends the lifespan of concrete structures, reduces maintenance costs, and minimizes the environmental impact associated with concrete production and use.
Funding: $500K+
Rough estimate of the amount of funding raised
Spiderwort
Spiderwort develops cellulose-based biomaterials to create scaffolds for regenerative medicine applications, including spinal cord injury repair and facial tissue augmentation. Their products, CelluBridge™ and CelluJuve®, aim to enhance tissue regeneration and aesthetic outcomes by providing a supportive framework for cellular growth.
Funding: $10M+
Rough estimate of the amount of funding raised
KAJI
The startup offers a self-awakening application that provides users with customizable immersive listening experiences through a selection of topics, workshops, and destinations. This platform facilitates personal growth and emotional well-being by enabling individuals to engage in transformative in-person healing journeys.
Funding: $500K+
Rough estimate of the amount of funding raised
Mussel Polymers, Inc.
This startup manufactures biomimetic adhesives inspired by the natural glue used by mussels, offering polymers like Poly Catechol Styrene for applications in coral restoration, ship repair, and medical and military fields. Their products provide clients with effective and durable restorative materials tailored to specific environmental and operational challenges.
Funding: $10M+
Rough estimate of the amount of funding raised
HekeTiss
HekeTiss has developed TrophiPatch, a cell-based skin patch utilizing adipose-derived stem cells to enhance the healing of chronic ulcers. This solution addresses the significant medical need for effective treatments for non-healing wounds, which affect over 1% of the global population.
Funding: $100K+
Rough estimate of the amount of funding raised
elecell
This company develops medical devices for tissue regeneration and wound healing. Their technology utilizes biomimetic currents to accelerate the body's natural healing processes, offering solutions for various medical conditions.
GeniPhys
GeniPhys is developing Collymer™, a patented polymerizable collagen technology that creates customizable scaffolds for tissue restoration and regeneration. This technology addresses the challenges of inflammation, fibrosis, and scarring in tissue integration by providing a stable, long-lasting support structure that promotes new tissue formation.
Funding: $500K+
Rough estimate of the amount of funding raised
Novaurum Biosciences
Novaurum Bioscience develops nano-biological coatings for medical implants. These coatings are designed to reduce post-surgical infections and accelerate the healing process for patients.
Funding: $300K+
Rough estimate of the amount of funding raised
NuVision
NuVision develops Omnigen, a wound dressing and grafting material made from preserved amniotic membrane, which retains its natural barrier function to promote healing in ocular surface diseases. The company addresses the need for rapid and accessible care for ocular injuries by ensuring that Omnigen tissue grafts are readily available for immediate use.
Funding: $5M+
Rough estimate of the amount of funding raised
ECM Therapeutics
ECM Therapeutics develops natural biomaterials that leverage the body's regenerative processes to promote healing in patients with tissue damage from injuries and diseases. Their technology enhances recovery outcomes by utilizing these biomaterials to stimulate tissue repair and regeneration.
Funding: $20M+
Rough estimate of the amount of funding raised
Osazda Energy
Osazda Energy develops MetZilla Paste and Plate Technologies to enhance the durability of solar cells by enabling self-healing of cell cracks, which are a major cause of long-term performance degradation. This technology allows for the use of thinner, cost-effective solar panels in various applications, ultimately increasing energy output and reducing operational costs.
Funding: $1M+
Rough estimate of the amount of funding raised
FractalEV
This company manufactures EV chargers designed for easy installation and configuration, featuring self-healing capabilities and OCPP compliance. Their chargers include an integrated operation and maintenance solution, aiming to improve uptime and reduce service visits for EV charging infrastructure.
Tetrous
The startup develops demineralized bone fiber materials that promote tissue remodeling similar to natural bone-tendon enthesis, specifically targeting Enthesis Failure Syndrome. This technology enables surgeons to perform minimally disruptive procedures in rotator cuff workflows, enhancing biological performance and integration with existing surgical techniques.
Funding: $5M+
Rough estimate of the amount of funding raised
NanoTess
NanoTess develops the NanoSALV Catalytic Advanced Wound Care Treatment Matrix, a Health Canada-approved medical device that utilizes solid-state heterogeneous biocatalysts to enhance natural wound healing. This technology significantly improves healing speed by approximately 57.6% and reduces wound care costs by around 46%, addressing the challenges of chronic wounds and skin health.
Asclepii
Asclepii develops Artemis™, a scalable tissue regeneration matrix that enhances cell-to-cell and cell-to-matrix interactions to improve wound healing outcomes. The company addresses the gap in regenerative medicine technology between cell therapy and traditional bandages, providing a platform for chronic wound care and potential organ manufacturing.
innovmater
INNOVMATER develops inorganic concrete admixtures and nanotech-based metamaterials that enable self-healing of micro-cracks and structural health monitoring in concrete infrastructure. These technologies extend the service life of critical structures, reduce maintenance costs, and enhance operational efficiency.
BioMimir
The startup designs and manufactures biodegradable, non-toxic hydrogels made from synthetic biomimetic polymers that can be tailored for specific elastic properties. These materials are intended to reduce inflammation and enhance the delivery of medications for wound healing and tissue repair in clinical settings.
Funding: $300K+
Rough estimate of the amount of funding raised
Serigen Mediproducts
Serigen develops tissue regeneration products utilizing natural silk proteins to create osteoconductive bone void fillers, absorbent wound dressings, and soft tissue matrices. These products address the clinical needs of patients with complex wounds, bone defects, and soft tissue injuries by promoting faster healing and regeneration.
Celloram Inc.
The startup develops cell therapies and small molecule therapeutics that utilize the body's innate healing mechanisms to treat cancer, autoimmune diseases, chronic inflammation, and metabolic disorders. By enhancing the self-healing process, the company aims to improve patient outcomes in managing these chronic illnesses.
Funding: $5M+
Rough estimate of the amount of funding raised
SmartWeave
Smartweave develops personalized, bio-compatible implants for soft tissue repair using AI-driven design and 3D printing technologies. Their approach addresses the high rates of infection and inflammatory reactions in surgical procedures by creating tailored biomaterials that enhance healing and prevent recurrence.
Vira Regen Inc.
This company develops bioelectronic medicines that target specific genes to accelerate bone fracture healing and treat musculoskeletal injuries, osteoarthritis, osteoporosis, and cancer. Their technology harnesses the body's natural self-repair mechanisms to address the root causes of these conditions.
Naturacur Wound Healing
Naturacur Wound Healing develops WoundCur gel, a clinically tested topical treatment designed to enhance healing for both acute and chronic wounds. This gel utilizes advanced hydrogel technology to create a moist wound environment, promoting faster recovery and reducing the risk of infection.
Land of Verse
The startup operates an online marketplace that connects users with traditional healing arts, focusing on practices that enhance physical and spiritual well-being. By fostering a community of practitioners and learners, the platform provides accessible resources for individuals seeking to improve their health and purpose through ancient healing techniques.
Funding: $100K+
Rough estimate of the amount of funding raised